Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

16.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
16.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetically Confirmed Localized Perianal Hailey-Hailey Disease Successfully Treated With Topical Difamilast: A Case Report.

Cureus·2026
Same author

Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome Associated With Relugolix Therapy for Giant Uterine Fibroids and Anemia: A Case Report.

Cureus·2026
Same author

Downhill Esophageal Variceal Rupture Caused by Superior Vena Cava Syndrome in NUT Carcinoma: A Case Report.

Cureus·2026
Same author

Neuronal TDP-43 regulates myelin formation via neurexin 1 mRNA stabilization.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Postnatal upregulation of cyclooxygenase-2 (COX-2) drives anatomical closure of the ductus arteriosus.

American journal of physiology. Heart and circulatory physiology·2026
Same author

MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma.

Cancer letters·2026
Same journal

Therapeutic potential of crude protein extracts from two Egyptian freshwater snails Lanistes carinatus and Bellamya unicolor.

Scientific reports·2026
Same journal

Microbial contamination of donor corneas and post-keratoplasty endophthalmitis: a comparison between Japanese and U.S. eye banks using cold storage.

Scientific reports·2026
Same journal

Prevalence and contributing factors of virological non-suppression among adult patients on first-line antiretroviral therapy in tertiary hospitals in Ethiopia.

Scientific reports·2026
Same journal

An in vitro comparison of color stability between alkasite and different restorative materials in various staining solutions.

Scientific reports·2026
Same journal

Toward accessible mRNA LNP formulation: systematic evaluation of mixing strategies and key parameters.

Scientific reports·2026
Same journal

A network analysis of personality traits, mentalizing, and psychological health in Chinese college students.

Scientific reports·2026
See all related articles

Related Experiment Video

Updated: Nov 13, 2025

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
12:31

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

14.3K

Antibody design using LSTM based deep generative model from phage display library for affinity maturation.

Koichiro Saka1, Taro Kakuzaki1, Shoichi Metsugi1

  • 1Research Division, Chugai Pharmaceutical Co., Ltd, Kamakura, Kanagawa, Japan.

Scientific Reports
|March 13, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a deep learning approach using Long Short-Term Memory (LSTM) networks to accelerate therapeutic antibody development. The machine learning method efficiently discovers high-affinity antibody sequences, significantly improving upon traditional methods.

More Related Videos

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.9K
A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits
12:36

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

Published on: February 16, 2014

34.6K

Related Experiment Videos

Last Updated: Nov 13, 2025

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
12:31

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

14.3K
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.9K
A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits
12:36

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

Published on: February 16, 2014

34.6K

Area of Science:

  • Biotechnology
  • Immunology
  • Computational Biology

Background:

  • Therapeutic antibody development relies on molecular evolution and affinity maturation.
  • Current affinity maturation techniques are costly and time-consuming due to extensive mutation experiments.
  • Exploring antibody sequence space efficiently is crucial for discovering high-affinity antibodies.

Purpose of the Study:

  • To develop an efficient deep learning-based method for antibody sequence generation and prioritization.
  • To apply this method for the affinity maturation of antibodies targeting kynurenine.
  • To demonstrate the superiority of the machine learning approach over traditional screening methods.

Main Methods:

  • Utilized a Long Short-Term Memory (LSTM) network, a deep generative model, for sequence generation.
  • Employed phage display panning with a kynurenine-binding oriented human synthetic Fab library.
  • Trained the LSTM model using next-generation sequencing (NGS) data of binding antibody sequences.
  • Correlated the likelihood of generated sequences with their binding affinity.

Main Results:

  • The trained LSTM model effectively generated antibody sequences with high binding affinity.
  • Generated antibody sequences exhibited over 1800-fold higher affinity compared to the parental clone.
  • The machine learning approach outperformed frequency-based screening in identifying high-affinity sequences.

Conclusions:

  • Deep generative models like LSTM can significantly enhance the efficiency of antibody affinity maturation.
  • This computational approach offers a cost-effective and faster alternative to traditional experimental methods.
  • The developed method holds promise for accelerating the discovery of novel therapeutic antibodies.